Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

DC...Wouldn't "Lung Cancer" be considered a "Women's Cancer"...Provista Diagnostics plans to expand their Breast Cancer Diagnostic pipeline..Why wouldn't they expand the "Lung Cancer" pipeline for women...Some here would consider that a ludicrous idea you understand..Wolf


Breast Cancer Facts

In the US, breast cancer is the most common cancer among women, after skin cancer, and the second leading cause of cancer death in women, after lung cancer.1

"Upon commercial launch, Videssa Breast will have data from two separate prospective randomized clinical trials with more than 1,350 patients from 15 breast cancer centers across the US. We plan to continue expanding our breast cancer diagnostic pipeline by developing additional panels to broaden clinical indications."

http://104.130.3.28/home/diagnostic-pipeline/breast-cancer-detection